Avalo Therapeutics, Inc. (AVTX) Q1 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Avalo Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:05.151 Greetings, and welcome to the Horizon Technology Finance Corporation first quarter 2024 00:00:05.151 -- 00:00:10.634 earnings conference call. At this time, all participants are in a listen-only mode. 00:00:10.634 -- 00:00:14.156 A question and answer session will follow the formal presentation. 00:00:14.156 -- 00:00:18.137 If anyone should require operator assistance during the conference, please press star 00:00:18.137 -- 00:00:23.400 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:23.400 -- 00:00:27.642 It is now my pleasure to introduce your host, Megan Bacon, Director of Investor Relations 00:00:27.642 -- 00:00:31.243 and Marketing. Thank you. You may begin. 00:00:31.243 -- 00:00:35.944 Thank you, and welcome to Horizon Technology Finance Corporation's first quarter 2024 00:00:35.944 -- 00:00:41.265 conference call. Representing the company today are Rob Pomeroy, Chairman 00:00:41.265 -- 00:00:46.307 and Chief Executive Officer, Jerry Michaud, President, Dan Dvoracic, 00:00:46.307 -- 00:00:51.308 Chief Operating Officer and Chief Investment Officer, and Dan Trollio, Chief Financial 00:00:51.308 -- 00:00:56.365 Officer. I would like to point out that the Q1 earnings press release and Form 00:00:56.365 -- 00:01:01.587 10-Q are available on the company's website at horizontechfinance.com. 00:01:02.048 -- 00:01:06.811 Before we begin our formal remarks, I need to remind everyone that during this conference 00:01:06.811 -- 00:01:11.453 call, the company will make certain forward-looking statements, including statements 00:01:11.453 -- 00:01:14.995 with regard to the future performance of the company. 00:01:14.995 -- 00:01:20.158 Words such as believes, expects, anticipates, intends, or similar...